Major depressive disorder - vortioxetine [ID583]: committee papers
Table of contents
1 Pre-Meeting Briefing by NICE
2 Submission from the technology manufacturer – Lundbeck
3 NICE request to the manufacturer for clarification on their submission
4 Manufacturer clarification response
5 Clinical expert personal perspective from Professor Heinz Grunze
6 Evidence Review Group report prepared by York
7 Evidence Review Group - clarifications
8 Manufacturer factual accuracy check of Evidence Review Group report
9 Manufacturer factual accuracy check - response
Major depressive disorder - vortioxetine [ID583]: committee papers
10 June 2015 (6.86 Mb 5 sec) |
This page was last updated: 10 June 2015